Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 14 May 2010
At a glance
- Drugs Carboplatin; Paclitaxel; Sunitinib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2009 Planned number of patients changed from 83 to 84 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.